Cheap fluid may shield heart better during surgery

NCT ID NCT06414330

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested two different solutions used to protect the heart during bypass surgery. One is a modified version of a common fluid (Ringer acetate), the other is a standard solution (HTK). Researchers checked which one led to fewer abnormal heart rhythms and less heart muscle damage after surgery. 124 adults having coronary bypass surgery took part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ringer acetate based modified Del Nido cardioplegia solution

What this could lead to

If it works, this could show that a cheaper, widely available fluid protects the heart better during surgery, reducing complications.

What could go wrong

This is a small, completed trial with 124 patients, so results may not apply to all heart surgeries. The benefit over standard care may be small or absent.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ISCHEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Assiut university, faculty of medicine, anesthesia and ICU and pain management department

    Asyut, Asyut Governorate, 71515, Egypt